← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fasgen, Inc.
Baltimore, MD
$7,829,200
Total funding
6
Grants
Funding over time
peak $1.9M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$7,829,200 · 6
By mechanism
R44$6,270,962 · 2
R43$1,558,238 · 4
Investigators at Fasgen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Small Molecule Therapeutics to Treat Obesity$980,497
R44 · FY2005 · DK
Novel Small Molecule Therapeutics to Treat Obesity$723,900
R44 · FY2009 · DK
Novel Small Molecule Therapeutics to Treat Obesity$723,900
R44 · FY2010 · DK
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$649,809
R44 · FY2004 · CA
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$648,424
R44 · FY2005 · CA
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$647,307
R44 · FY2006 · CA
Novel Small Molecule Therapeutics to Treat Obesity$559,756
R44 · FY2006 · DK
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$545,559
R44 · FY2007 · CA
Novel Small Molecule Therapeutics to Treat Obesity$541,950
R44 · FY2007 · DK
Treatment of Latent TB and MDR-TB with FAS20013$300,413
R43 · FY2005 · AI
Novel Compounds for Improved Treatment of Tuberculosis$278,254
R43 · FY2002 · AI
Novel Compounds for Improved Treatment of Tuberculosis$257,441
R43 · FY2003 · AI
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$249,860
R44 · FY2003 · CA
Novel Small Molecule Therapeutics to Treat Obesity$249,684
R43 · FY2003 · DK
Treatment of Latent TB and MDR-TB with FAS20013$147,456
R43 · FY2006 · AI
Novel Small Molecule Therapeutics to Treat Obesity$124,990
R43 · FY2004 · DK
Fatty Acid Synthase Phosphorylation as a Cancer Biomarker$100,000
R43 · FY2007 · CA
Fatty Acid Synthase Phosphorylation as a Cancer Biomarker$100,000
R43 · FY2008 · CA